
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
IPM.ai, part of Real Chemistry (www.ipm.ai), transforms real world data into real world insights that uncover the ideal patient and their healthcare ecosystem so that life sciences companies can accelerate the commercialization of precision therapies for specialty and rare diseases that lead to optimal patient outcomes quicker, with less risk. IPM.ais Insights as a Service (IaaS) platform optimizes drug development, clinical study, product launch and commercial operations by utilizing granular-level longitudinal analytics, artificial intelligence and machine learning in conjunction with a real world data universe of over 300 million de-identified patient journeys and 65 billion anonymized social determinants of health...
Real world evidence,real world data,machine learning,deep learning,patient finding,treatment journey,market intelligence,market segmentation,patient engagement,patient profile,clinical trial recruitment,drug commercialization,drug discovery,speciality disease,rare disease,orphan drug,hcp intelligence,drug research,nai accredited,and hipaa
Ipm.ai operates in the Information services industry.
Ipm.ai's revenue is 11m - 100m
Ipm.ai has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.